Abstract: Myelin P2 protein is a small (14,800 Da) protein found in peripheral and central nervous system myelin. To investigate the regulation of expression of this myelin protein, a mouse genomic library was screened with a rabbit P2 cDNA (pSN2.2-2), and a single positive phage clone containing a 20-kb insert was obtained. This insert contained a single internal SalI restriction site and several EcoRI sites. The EcoRI fragments from this insert were subcloned into Bluescript. The rabbit P2 cDNA (pSN2.2-2) hybridized with a 4-kb EcoRI fragment, and this 4-kb fragment was then sequenced after the creation of nested deletions. The mouse gene contained four exons: exon 1 coded for amino acids 1-24, exon 2 for amino acids 24-8 1, exon 3 for amino acids 82-1 15, and exon 4 for amino acids 1 16-13 1. The three introns were 1.2 kb, 150 bp, and 1.3 kb in length. Primer extension analysis revealed two transcription start sites at + 1 and +47, consistent with the presence of two P2 mRNAs, with the larger transcript appearing more abundant. The amino acid sequences predicted from the mouse DNA indicate that the mouse protein differs from the rabbit protein at 16 different positions, with most of the differences located in exon 3. When the gene structure of fatty acid binding protein (FABP) genes were compared, the P2 gene had the same overall structure as others in the FABP family, suggesting a common ancestral gene for members of this family. The 5'-flanking region contains candidate TATA and CAAT sequences, as well as two AP-1 binding sites that may be important in modulation of the expression of this gene. Myelin, a structure unique to the nervous system, is a specialization of the plasma membrane of Schwann cells and oligodendrocytes. It is composed predominantly of lipids, with proteins accounting for about 30% of its wet weight. Myelin obtained from the central and peripheral nervous systems contains many different proteins. Although the function of many of these proteins has been open to speculation, only Po protein, myelin basic proteins, proteolipid protein, and myelinassociated glycoproteins appear to play important roles in establishing and maintaining the lamellar structure of compact myelin (Lemke, 1988; Filbin et al., 1990) .
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Myelin, a structure unique to the nervous system, is a specialization of the plasma membrane of Schwann cells and oligodendrocytes. It is composed predominantly of lipids, with proteins accounting for about 30% of its wet weight. Myelin obtained from the central and peripheral nervous systems contains many different proteins. Although the function of many of these proteins has been open to speculation, only Po protein, myelin basic proteins, proteolipid protein, and myelinassociated glycoproteins appear to play important roles in establishing and maintaining the lamellar structure of compact myelin (Lemke, 1988; Filbin et al., 1990) .
P2 is a small (14,800 Da) basic protein found in myelin and in the cytosol of Schwann cells and oligodendrocytes and whose expression increases during myelination (Narayanan et al., 1988) . The function ofthis protein may be inferred from its amino acid sequence and tertiary structure determined by x-ray crystallography. P2 bears a striking similarity in amino acid sequence to a family of fatty acid binding proteins (FABPs) from various tissues, including the mouse adipocyte FABP (aP2/422); rat liver, intestinal, and heart FABPs; and the cellular retinol and retinoic acid binding proteins (Narayanan et al., 1988) . Crystallographic studies have revealed that the tertiary structures of bovine myelin P2 protein (Jones et al., 1988) and rat intestinal FABP (Sacchettini et al., 1988) are very similar to each other, each consisting of two layers of &sheet structure enveloping a hydrophobic pocket in which a fatty acid ligand is camed. Studies demonstrating that bovine P2 protein specifically binds oleic acid, retinol, and retinoic acid support this idea (Uyemura et al., 1984) .
Unlike other myelin proteins, the myelin P2 protein varies considerably in abundance in different species; P2 accounts for < 1% of myelin proteins in rat or mouse sciatic nerves but makes up 5-12% of myelin proteins in human, bovine, and rabbit nerve roots (Greenfield et al., 1973 (Greenfield et al., , 1982 . Another fact that remains unexplained is the tissue distribution of P2 protein, with P2 protein most abundant in peripheral nerves and nerve roots, less abundant in spinal cord, and least abundant in the brainstem and cerebrum (Trapp et al., 1983) . Whether these species differences and the tissue distribution within a single species reflect variations in fatty acid metabolism is uncertain.
To investigate the mechanisms mediating the differential expression of this protein in various parts of the nervous system and the variability in protein abundance among different species, we have c1one:d the mouse myelin P2 protein gene. In this report, we present the structural characteristics of this gene and compare it to other genes in the FABP family.
METHODS AND RESULTS
A genomic library was constructed in the bacteriophage vector, h EMBL3, representing nuclear DNA extracted from cultured mouse 3T3-Ll adipocytes (Ntambi et al., 1988) . In brief, genomic DNA isolated from cultured cells was partially digested with MboI and size-fractionated by sucrose density gradient centrifugation to separate fragments about 20 kb long (Maniatis et al., 1982) . X EMBL3 arms, digested with BamHI, were obtained from Stratagene. Vector fragments and MboI-digested, genomic DNA were ligated, packaged in vitro with Gigapack Gold packaging extract (Stratagene), and titered with P2392 indicator cells. The library was amplified once before screening.
This genomic library was screened with a pSN2.2:-2, P2 cDNA probe (Narayanan et al., 1988) at reduced stringency (0.1 X SSC/O. 1% sodium dodecyl sulfate washed at 55°C; 1 X SSC is 0.15 M NaCl, 0.0 15 M Na3 citrate). A single positive phage clone, designated L25-1, containing a 20-kb insert was identified out of about 1 X lo6 recombinants. The insert contained a single internal SalI restriction site and several EcoRI and BamHI sites (Fig. 1) . Each of the fragments that resulted when the phage DNA was digested with BumHI, EcoRI, BamHI and SalI, or EcoRI and SalI was subcloned into a plasmid (Bluescript, Stratagene). By a series of crosshybridization experiments with these subclones, overlapping segments were identified, and the restriction sites were mapped ( Fig. 1) . The rabbit Pa cDNA clone (pSN2.2-2) hybridized to a single 4-kb EcoRI fragment of the L25-1 phage DNA. This segment, GPR-10, was sequenced entirely by creating nested deletions with exonuclease 111 (Henikoff, I984) , starting at either end of the insert (Fig. 1 ). Comparing the nucleotide sequence of the GPR-10 with the rabbit P2 cDNA sequence and a partial sequence of a murine P2 cDNA clone (Monuki et al., 1989 and sequence information provided by G. Lemke) allowed us to distinguish between the coding region and introns. The mouse gene codes for a 131-amino acid protein, differing from the rabbit P2 at 16 residues, with most of these differences occurring in exon 3. These amino acid differences are indicated in Fig. 2 . The nucleotide sequences at the splice junctions at the 5' and 3' ends of introns 1, 2, and 3 are all consistent with the 5'-GT . . . AG-3' rule (Breathnach and Chambon, 198 1) .
We have identified two sites of transcription initiation by primer extension analysis. Total RNA was extracted from sciatic nerves of 10-day-old mice and adult mouse brain by using the acid guanidinium isothiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) . A synthetic oligonucleotide MP2Pr-Ex (Y-CTTTCATGT-AGTCATCGA-3') complementary to the protein coding region of exon 1 of the mouse P2 gene (Fig. 2) was end labeled to a specific activity of 5 X lo6 cpm/pmol using [T-~~PIATP (>6,000 Ci/mmol) and T4 polynucleotide kinase (Maniatis et al., 1982) . Conditions for annealing the primer to the RNA and for extension were as described previously by Ntambi et al. (1988) . Twenty micrograms each of yeast tRNA, mouse sciatic nerve RNA, or mouse brain RNA was annealed to 0.1 pmol of 32P-labeled primer and extended with avian myeloblastosis virus reverse transcriptax. The reaction products were analyzed on a 6% polyacrylamide, 7 M urea sequencing gel, together with Sanger dideoxy sequencing reaction products of the genomic clone, GPR-10, as template and the MP2Pr-Ex oligonucleotide as primer (Fig. 3) . These data indicate two transcription start sites and, thus, the presence of two P2 mRNAs, with the larger transcript perhaps being more abundant, because it always gave a darker band on autoradiograms after primer extension analysis. However, additional studies will be required to confirm whether there are indeed two P2 mRNAs.
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DISCUSSION
One goal of our research is a molecular biological characterization of the events underlying myelination. These events include (a) the surface interaction between Schwann cell or oligodendrocyte and the axon; (b) the extracellular signals that induce the synthesis of lipids and myelin-specific proteins, which are then assembled into the vast surface area of myelin membrane; and (c) the intraceflular messengers that mediate these changes. These processes involve regulation of gene transcription, mRNA translation, or posttranslational events. For a better understanding of these events, we have begun an analysis of the myelin P2 protein gene and its regulatory elements. We had earlier characterized a cDNA encoding rabbit myelin P2 protein (Narayanan et al., 1988) . By using this as a probe, we have isolated and characterized the protein coding segment of the mouse Pz gene.
We believe the gene we have characterized is the myelin P2 gene and not the closely related aP2/422 gene. Direct comparison of the nucleotide sequences of the two genes (Phillips et al., 1986; Hunt et al., 1986) , examination of the sequence of the murine P2 cDNA clone (Monuki et al., 1989) with the exon sequence of the mouse P2 gene, and the results of the primer-extension experiments done with mouse sciatic nerve RNA and a primer complementary to a segment in the first exon in GPR-10 further support the contention that this gene is the mouse myelin P 2 gene. The exon/ intron structure of this gene has been assigned by comparing the rabbit PZ cDNA and the murine P2 sequence with the genomic sequence. This mouse Pz gene is divided into four exons by three introns, 1.2 kb, 150 bp, and 1.3 kb in length. We have compared the sequence of the mouse PL gene with that of the mouse aP2/422 gene, the rat liver FABP (Sweetser et al., 1986) , the cellular retinol binding protein-I1 gene (Demmer et al., 1987) , and the cellular retinoic acid binding protein gene (Shubeita et al., 1987) (Fig. 4) . Each of these genes has the same overall structure containing four exons, but the sizes of the introns are quite different. The sites of the exon/intron boundaries occur at similar positions in the amino acid sequence in each of these genes. For instance, the first splice site occurs at a glycine residue (23, 24, or 25 depending on the numbering of the amino acids), and the second occurs at a lysine residue (80, 81, 82, or 84) in four of the five genes (Fig. 4) . This degree of similarity strongly supports the idea that these various genes evolved from a common anclestral gene.
We have also sequenced about 1 kb of the 5'-flanking region of this gene, part of which is shown in Fig. 2 . This 5'-flanking sequence contains an AT-rich region, which is a candidate TATA element, and two CAATbox sequences, elements that are found in most eukaryotic promoters (Dynan and Tjian, 1985; Maniatis et al., 1987) . Also interesting, a 53-bp direct repeat occurs immediately before the translation initiation site (Fig. 2) . The two transcription initiation sites for P2 mRNA lie at the 5' end of this directly repeated sequence, and by primer extension analysis, the larger transcript is perhaps the more abundant message. Another interesting sequence motif, 5'-TGAGTCA-3', occurring twice in this region, is a potential binding site for proteins in the AP-1 family (Fig. 2) . These proteins that alter gene transcription are sequence-specific DNA-binding proteins that interact with enhancer elements in various genes (Curran and Franza, 1988; Turner and Tjian, 1989) . The induction of specific genes by phorbol esters appears to be mediated by the binding of AP-1 proteins to these target sequences (Angel et al., 1987; Lee et al., 1987) . Also, at least two oncogene products, Jun and Fos, belong to a family of transcriptional factors that bind directly or indirectly to the consensus AP-1 binding site (Curran and Franza, 1988; Turner and Tjian, 1989) and alter gene transcription. When investigating gene expression in adipocyte differentiation, Spiegelman and his colleagues identified similarities in the sequences of the 5'-flanking regions of three genes (Phillips et al., 1986) . One of these sequences, S-CATGACTCAGAGGAAAAC-ATAC-3', called the fat-specific element 2 (FSE-2), occurs in the 5'-flanking region of the aP2 1422 gene and the glycerol-3-phosphate dehydrogenase gene. In the aP2/422 gene, the FSE-2 element contains a consensus AP-1 binding site and binds a protein complex containing Fos (Distel et al., 1987; Rauscher 111 et al., 1988) . This protein complex appears to regulate aP2/ 422 gene activity in preadipocytes (Rauscher et al., 1988; Christy et al., 1989) , although there is no similar sequence to FSE-2 in the mouse P2 promoter. Identification of two consensus AP-1 binding sites in the mouse P2 gene is of interest, because Monuki et al. (1989) have shown that, in rat Schwann cells in vitro, the induction of myelin Po and P2 gene expression by forskolin is preceded by a fall in intracellular c-jun expression. This finding led them to speculate that the Jun protein down-regulates the expression of myelin genes by binding AP-1 binding sites. In preliminary studies with nuclear extracts containing c-jun, the mouse myelin P2 promoter containing the AP-1 binding sites resulted in a shift of the labeled DNA fragment by DNA mobility shift assay (data not shown, Narayanan and Tennekoon). Whether this binding results in altering transcription is yet to be determined. Furthermore, comparison of sequence homologies in the 5'-flanking region with other genes coding for FABPs or for myelin proteins reveals no homologies. Currently, we are attempting to study how the myelin P2 gene is regulated during myelinogenesis. 
